ETF profile for Milliman Healthcare Inflation Plus ETF (MHIP) from the issuer: top holdings, net assets, expense ratio and shares outstanding.
MHIP ETF Profile
| Family: |
Milliman |
| Name: |
Milliman Healthcare Inflation Plus ETF |
|
|
| Inception Date: |
7-Apr-2026 |
| Termination Date: |
|
| Investment Objective: |
Milliman Healthcare Inflation Guard ETF investment objective is to seek to generate return that over time exceed the U.S. healthcare cost inflation. The fund invests in a combination of assets that Milliman Financial Risk Management LLC, the Fund's investment adviser ("Milliman"), believes will produce returns that are generally equivalent to the U.S. healthcare cost inflation rate. The fund invests in healthcare companies include U.S.-listed common stocks and ADRs issued by companies in the healthcare sector and companies involved in the U.S. healthcare supply chain, as well as corporate bonds issued by such companies; and instruments that Milliman believes are expected to hedge against the U.S. healthcare cost inflation rate include commodities, TIPS and Treasury bonds. Milliman utilizes a proprietary quantitative model (the "Quantitative Model") that is based on its extensive research and analysis on the interrelationships and interactions of the performance of equity securities, debt securities and commodities relative to the U.S. healthcare cost inflation rate. |
|
|
| Prospectus |
|
|
|
| Top 10 Holdings |
|
|
| United States Treasury Bill 11/19/2026 |
B 0 11/19/26 |
19.0400% |
| State Street SPDR Portfolio S&P 500 ETF |
SPYM |
12.1800% |
| Eli Lilly & Co |
LLY |
11.3900% |
| Johnson & Johnson |
JNJ |
5.9400% |
| BondBloxx Bloomberg Five Year Target Duration US Treasury ETF |
XFIV |
3.8500% |
| AbbVie Inc |
ABBV |
3.2400% |
| BondBloxx Bloomberg Six Month Target Duration US Treasury ETF |
XHLF |
2.6400% |
| Gilead Sciences Inc |
GILD |
2.4900% |
| Thermo Fisher Scientific Inc |
TMO |
2.2600% |
| Amgen Inc |
AMGN |
2.0800% |
|
Top 10 Holdings Weight: |
65.1% |
| Number of Holdings: |
90 |
| Shares Outstanding: |
75,000 |
| Total Net Assets: |
1,618,132 |
| NAV: |
21.56 |
| Net Expense Ratio: |
0.55% |
|
|
| Asset Class: |
Equities (Stocks) |
| Developed or Emerging: |
Developed Market Funds |
| Country: |
US |
| Region: |
|
| Strategy: |
Other Quant Model |
| Currency: |
|
| Commodity: |
|
| Sector: |
Healthcare |
| Industry: |
|
| Dividend Type: |
|
| Tax Exempt State: |
|
| Maturity Duration: |
|
| Market Cap: |
Broad Market / Multi-Cap |
| Credit Quality: |
|
| Mortgage Bond Types: |
|
| Bond Type: |
|
| Gov't Bond Types: |
|
| Reit Type: |
|
| Leverage Direction/Factor: |
|
| Is Currency Hedged: |
No |
| US or Ex-US: |
Domestic |
